» LEARN MORE ABOUT COVID-19 VACCINES, TESTING, VISITOR & SAFETY REQUIREMENTS

MyHealth

Manage your account, request prescriptions, set up appointments & more.

LOG IN
Don't have an account
Contact Us
    • see more mega-menu-label
    • see more mega-menu-label
    • see more mega-menu-label
    • see more mega-menu-label
    • see more mega-menu-label
    • see more mega-menu-label
    • see more mega-menu-label

Pycnogenol for Menopausal Symptoms

Trial

Clinical Trial Title

The Use of Pycnogenol® to Alleviate Menopausal Symptoms Induced or Increased by Breast and Gynecological Cancer Treatments

Trial Status

Closed to Enrollment

Start Date

October 9, 2018

Trial Type

Cancer - Adult Oncology

Specific Condition

Breast Cancer

Description

This is a pilot study to test whether PYC can improve climacteric symptoms for women who have experienced either surgically or medically induced menopause as part of their treatment for breast or gynecologic cancers.

Eligibility Criteria

Inclusion Criteria:

  • Patient currently is undergoing treatment for cancer
  • Patient has menopausal symptoms induced either by surgical or medical (patient on tamoxifen or aromatase inhibitor) interventions for cancer
  • Willing to stop other supplements or medications that are aimed at treating menopausal symptoms at least 7 days before beginning study treatment

Exclusion Criteria:

  • Menopausal symptoms are unrelated to surgical or medical treatment of breast or gynecologic cancers

Please contact Legacy Oncology Research for additional study inclusion/exclusion information.

 

IRB Number

Central IRB

Principal Investigator Name

Reza Antoszewska, MS NP-C

Contact Name

Oncology Clinical Research

Phone

503-413-8199

Contact Fax

503-413-6920

Contact E-Mail

oncologyresearch@lhs.org

Last Updated: Wednesday, January 27, 2021 12:56:54 PM